A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade gastroenteropanncreatic or lung neuroendocrine carcinoma Article

Web of Science: 000530922700613

Cited authors

  • Ramirez, Robert A.; Matrana, Marc Ryan; Satti, Suma; Griffin, Ryan Patrick; Voros, Brianne A.; Bren-Mattison, Yvette

Publication date

  • 2020

Published in

International Standard Serial Number (ISSN)

  • 0732-183X


  • 38


  • 4